The molecular functions of CDH2 and its ANGs in patients with ACC included structural constituents of synapses, histone deacetylase binding, monoatomic ion transmembrane transporter activity, ATP hydrolysis activity, protein kinase binding, calcium ion binding, and protein homodimerization activity (Figure 2g). This evidence concerns the gene CDH2 and adrenal cortex carcinoma.